Superior vena cava syndrome
Superior vena cava syndrome (SVCS) consists of various symptoms arising from dysfunction of the superior vena cava. While the cause of SVCS can be infectious, inflammatory, thromboembolic or malignant, malignancies account for up to 90% of causes. In the setting of malignancy, obstruction can be caused by either invasion or external compression of the superior vena cava (SVC) by a pathological process or by (coexistent) thrombosis of blood within the SVC. SVCS affects up to 10% of small cell lung cancer (SCLC) patients and up to 2–4% of all lung cancer patients [3]. SVCS is determined by increased venous pressure in the upper body from the SVC obstruction and manifests with easily discernible symptoms on clinical examination, including oedema of the head, neck, eyelids, upper torso, arms and distinctly dilated veins. Laryngeal and pharyngeal oedema may cause narrowing of the respiratory tract [4]. Chest radiograph may show a bulky mass, whereas computed tomography (CT) with intravenous contrast is the imaging modality of choice for more detailed visualisation of the SVC and to depict the relationship of the tumour with the SVC (Fig. 1). For optimal evaluation of the SVC, CT of the chest is best perfomed 60 s after peripheral intravenous injection of 120 mL iodinated contrast at a rate of 3 mL/s [5]. However, SVCS is frequently diagnosed on routine contrast-enhanced chest CT. In case of thrombosis, CT shows a filling defect in the superior vena cava, often caused by direct invasion by a malignancy arising from the lungs or mediastinum. Streak artefacts due to non-enhanced blood from contralateral veins should not be mistaken for a thrombus. Secondary signs such as a collateral vascular network may also point to the diagnosis of an occluded or compressed SVC. On CT, these collateral veins appear as densely opacified tortuous vascular channels. The most commonly visible venous collateral network is the azygos and hemiazygos system, which is an important ancillary CT finding of SVCS. Other important thoracic venous collaterals are the vertebral and subscapular plexuses, the mediastinal, oesophageal, and diaphragmatic venous plexuses, and the lateral thoracic and superficial thoracoabcominal venous plexuses [6]. Coronal reformatted images are often helpful to delineate the extent of the SVC thrombus or compression. Patients with lung cancer presenting with SVC, who need emergency treatment, should receive urgent chemoradiotherapy with or without endovascular stenting for rapid symptom relief as well as to optimise overall outcome and prevent recurrence of SVCS [4].
Massive pulmonary embolism (PE)
Compared to the general population, cancer patients carry a higher risk for development of venous thromboembolism (VTE), including PE and deep venous thrombosis (DVT). It is estimated that cancer is responsible for 20% of all cases of VTE and lung cancer is amongst the malignancies with the highest incidence rates [7]. Risk factors for VTE are advanced disease, chemotherapy treatment and treatment with anti-angiogenic agents [7]. Prevalence of asymptomatic PE in lung cancer outpatients has been estimated to be 14.9% [8]; consequently, diagnosis of incidental PE when contrast-enhanced CT is performed for other indications is relatively common. Clinical presentation of patients with PE is similar regardless of the cause of the pulmonary emboli, with symptoms of dyspnoea, chest pain and signs of right heart failure. The severity of the symptoms is related to the extension of embolism, the size of the clots and underlying heart or lung disease. If properly diagnosed and treated, there is no significant difference in survival rate between lung cancer patients with and without PE, and most deaths are attributable to disease progression [9]. However, because symptoms of PE such as dyspnoea and chest pain are non-specific and particularly common in lung cancer patients, the presence of PE is easily overlooked clinically, and radiologists play an important role in picking up incidental PE. CT pulmonary angiography (CTPA) is the imaging modality of choice and will show filling defects in the pulmonary vasculature (Fig. 2); when observed in the axial plane, this has been described as the “polo mint” sign. When pulmonary emboli are present, attention should be paid to the heart. Imaging findings that suggest right ventricular failure include right ventricular dilatation with or without contrast material reflux into the hepatic veins and/or deviation of the interventricular septum toward the left ventricle [10]. A right ventricle/left ventricle short axis ratio greater than 1 on reconstructed four-chamber views is indicative of right heart failure and a bad prognostic sign [11]. Peripheral wedge-shaped areas in the lung parenchyma may indicate lung infarction and should alert the radiologist to pulmonary embolism as a possible underlying cause.
Haemodynamic and respiratory support is the initial treatment of acute massive PE, followed by anticoagulation or, in the case of massive acute PE, fibrinolysis [12]. Treatment for patients with incidental, asymptomatic PE remains the same as for patients with symptomatic PE according to guidelines published by the American College of Chest Physicians [13].
Spontaneous pneumothorax
Spontaneous pneumothorax is a very rare complication of lung cancer with an estimated occurrence rate of 0.03-0.05% in primary lung cancer. Only 2% of all spontaneous pneumothoraces is coexistent with malignant lung diseases [14]. In approximately 75% of these cases, pneumothorax is the presenting feature of lung cancer [15]. The clinical presentation is variable, depending on the extent of the pneumothorax, ranging from asymptomatic to extreme dyspnoea with hypotension and tachycardia in case of tension pneumothorax, which can be life-threatening. In tension pneumothorax, a positive pressure on mediastinal and intrathoracic structures can result in a reduced cardiac output with typical features of hypoxaemia and haemodynamic compromise [16]. Erect chest radiograph is the imaging modality of choice for the initial diagnosis of a pneumothorax. CT is considered as the “gold standard” for the detection of a small (and anterior) pneumothorax and size estimation. The differentiation of a large from a small pneumothorax is made by identification of a rim of >2 cm between the lung margin and chest wall at the level of the hilum [16]. Moreover, CT can better identify the relationship with underlying lung pathology, such as lung cancer (Fig. 3). Particularly in older patients presenting with a spontaneous pneumothorax, CT images should be scrutinised for malignancy as a possible cause. A tension pneumothorax should be suspected if there are additional features such as a mediastinal shift to the contralateral side or depression of the ipsilateral hemidiaphragm.
Small, asymptomatic pneumothorax can be treated conservatively. Larger, symptomatic pneumothorax requires active intervention by needle aspiration or chest drain insertion [16].
Cardiac tamponade
Pericardial effusion in oncology patients may develop by four mechanisms: direct extension or metastatic spread, chemotherapeutic toxicity, radiation toxicity, or as an opportunistic infection [17]. Primary lung cancer is the most common cause, accounting for over one-third of malignant pericardial effusions. Only a small percentage of patients with a malignant pericardial effusion develop cardiac tamponade, which is a medical emergency [18]. Cardiac tamponade results from an accumulation of pericardial fluid leading to an impaired ventricular filling with decreased cardiac output. This can occur with as little as 200 ml of pericardial fluid [17, 19]. Symptoms suggestive of cardiac tamponade are dyspnoea, non-specific chest pain and fatigue.
Because of its high sensitivity for the detection of pericardial fluid, echocardiography is considered to be the primary imaging modality of choice to assess cardiac tamponade. Chest radiograph may show an enlarged cardiac silhouette with characteristic “water bottle” appearance. CT and magnetic resonance imaging (MRI) allow for a functional evaluation of the heart as well as characterisation of the pericardial effusion. CT findings of a thickened, enhancing or nodular pericardium and high-density fluid suggest a malignant pericardial effusion [20]. Signs suggestive of right heart failure are hepatic congestion and contrast reflux in the inferior vena cava and hepatic veins (Fig. 4). Other secondary findings indicative of a possible tamponade include enlargement of the SVC (diameter greater than the aorta), enlargement of the inferior vena cava (diameter greater than twice the adjacent aorta), periportal lymphoedema, angulation or bowing of the interventricular septum and flattening of the anterior surface of the heart (“flattened heart” sign) [21]. Though MRI is generally not used in the diagnosis of cardiac tamponade due to the emergent, life-threatening nature of the condition, MRI can be very useful in the evaluation of pericardial effusions, providing both morphological and functional information. MRI findings of a large haemorrhagic pericardial effusion with contrast-enhancing irregular or nodular pericardial thickening is suggestive of a metastatic pericardial effusion [22].
Since cardiac tamponade carries a high mortality, emergent pericardiocentesis, with or without placement of an indwelling pericardial drain, can be life-saving [17].
Massive haemoptysis
Massive haemoptysis is defined as expectoration of 100 ml of blood in a single episode or more than 600 ml of blood over a 24-h period. Massive haemoptysis is a life-threatening medical emergency, which is fatal in about one-third of cases. Bronchogenic carcinoma is the most common cause of massive haemoptysis in patients over 40 years old with an overall rate of haemoptysis of 10-20%, although only fatal in 3% [23]. In case of severe haemoptysis, the bleeding usually stems from bronchial (90%) and pulmonary (5%) arteries [24, 25].
Chest radiography might be the initial imaging modality since it is readily available. Chest radiography can assist in lateralising bleeding by demonstration of parenchymal and pleural abnormalities such as tumours and cavitary lesions. Multidetector CT may identify the bleeding site, cause and vascular origin of bleeding (bronchial arterial versus pulmonary arterial), while allowing a comprehensive evaluation of the lung parenchyma and mediastinum (Fig. 5). CT findings of active contrast extravasation, pseudo-aneursym formation and vessel invasion imply active bleeding [25]. Optimal arterial enhancement requires a tailored protocol with a region of interest positioned on the descending aorta. The scan should start during the peak enhancement (greater than 100 HU) after peripheral intravenous injection of a high-concentration contrast medium (350–400 mg/ml) at a flow rate of 3.5-5 mL/s [25].
In emergency, arterial endovascular embolisation is the procedure of choice while surgery may be performed in select cases when the patient is stabilised. Performing a multidetector CT angiography before endovascular treatment is useful to provide a detailed depiction of the origin and course of bronchial and non-bronchial systemic arteries responsible for haemoptysis and determine the optimal endovascular approach [25].
Central airway obstruction
Central airway obstruction can be caused by a myriad of malignancies but is most commonly caused by lung cancer extending directly into the airway lumen. Up to 30% of lung cancer patients will have tumour obstruction of the central airways at some point in the course of their disease [26]. Central airway obstruction usually manifests with symptoms of respiratory distress, including stridor and dyspnoea, haemoptysis, cough and fever due to post-obstructive pneumonitis [20].
Chest radiographs are non-sensitive and non-specific but may demonstrate tracheal narrowing or a hilar mass with retro-obstructive atelectasis or consolidation. The lateral radiograph can be of additional value because it provides a less obscured view of the trachea compared to the frontal view. Contrast-enhanced CT with coronal reconstructions is more sensitive and may identify the cause, site and severity of central airway obstruction and assess tumour extension (Fig. 6) [27]. Virtual bronchoscopy can be helpful for non-invasive evaluation of the tracheobronchial tree, allowing evaluation of the airways beyond a high-grade luminal obstruction not passable by a bronchoscope [28].
In case of severe airway obstruction, urgent therapeutic bronchoscopy with placement of airway stents is the treatment of choice [27]. To help determine the appropriate size of the stent, it is important to report the length of obstruction, the maximum degree of obstruction and the luminal diameter of the normal airways [29].
Oesophagorespiratory fistula
An oesophagorespiratory fistula (ERF) is a rare, life-threatening complication of lung cancer affecting less than 1% of patients [30, 31]. The trachea is most commonly involved but oesophagobronchial and oesophagopulmonary fistula can also develop occasionally. An ERF, in the setting of lung cancer, may develop either through direct erosion of tumour through adjacent structures into the oesophagus or, uncommonly, after initial treatment, in particular in patients treated with angiogenesis inhibitors and chemoradiation [32]. ERF typically presents with coughing, dyspnoea secondary to aspiration pneumonitis, recurrent pulmonary infections and poor nutrition.
Diagnosis is generally made clinically but can be confirmed on imaging. The imaging modality of choice is contrast oesophagography with a non-ionic water-soluble iodinated contrast medium. On CT, a direct communication between the oesophageal and airway lumens may be visualised, usually surrounded by soft-tissue thickening caused by underlying tumour (Fig. 7). In addition, orally ingested contrast material may be seen in the airway lumen and lung parenchyma. Multiplanar imaging with coronal and sagittal reconstructions may give more insight into the location and extent of the ERF. Associated findings, such as pulmonary consolidation, pleural fluid and abscess formation, can also be appreciated on CT.
Palliative stenting of the oesophagus and/or trachea is the treatment of choice [20].